Human EMAP-II/AIMP1 Protein (EAP-HE102)
KACTUS Biosystems Human EMAP-II/AIMP1 Protein (EAP-HE102) (catalog No. EAP-HE102) is expressed from E.coli with His tag at the N-Terminus.It contains Ala2-Lys312.
KACTUS Biosystems Human EMAP-II/AIMP1 Protein (EAP-HE102) (catalog No. EAP-HE102) is expressed from E.coli with His tag at the N-Terminus.It contains Ala2-Lys312.
KACTUS Biosystems Mouse EMAP-II/AIMP1 Protein (EAP-ME102) (catalog No. EAP-ME102) is expressed from E.coli with His tag at the N-Terminus.It contains Ala2-Lys310.
Purified human IgG (whole molecule) from a mixture of normal human serum. A human Fc blocking reagent or a component of a human Fc blocking solution. Recombinant mouse IgG antibody mixes and recombinant human IgG isotype controls are available.
Recombinant human IgG antibody mixes: animal free production; lot-to-lot consistency; no binding to human tissues; adjustable formulation of the human IgG antibodies in the antibody mixes. Best normal human serum alternative; normal human serum blocking...
The human CD64 Fc blocking antibody (M22 or H22 Fc blocking antibody) is an anti-human Fc receptor antibody for human FcR blocking reagent. Various isotypes are available for certain applications. Condition of sample preparation and...
Recombinant mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant rat IgG2a isotype controls and Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant mouse IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant rat IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant mouse IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.